Literature DB >> 15375711

PIVKA-II-producing advanced gastric cancer.

Shigetsugu Takano1, Ichiro Honda, Satoshi Watanabe, Hiroaki Soda, Matsuo Nagata, Isamu Hoshino, Toshinao Takenouchi, Masaru Miyazaki.   

Abstract

We describe the case of a 68-year-old man with primary advanced adenocarcinoma of the stomach, who displayed extremely high plasma levels of protein induced by vitamin K antagonist (PIVKA)-II (15 600 mAU/ml) and normal levels of alphafetoprotein (AFP) (4 ng/ml). Ultrasonography and dynamic computed tomography ruled out hepatocellular carcinoma (HCC) or liver metastasis. After preoperative chemotherapy, pancreatico-spleno total gastrectomy with D2 lymphadenectomy was performed. Postoperatively, plasma levels of PIVKA-II returned to within the normal range (29 mAU/ml). Microscopic examination revealed stomach adenocarcinoma showing various histological types, such as moderately to poorly differentiated mucinous adenocarcinoma, but hepatoid differentiation of gastric adenocarcinoma was not detected. Localization of PIVKA-II and AFP within tumor cells was demonstrated by immunohistochemical staining using monoclonal antibodies. These results indicate that tumor cells from gastric cancer may produce PIVKA-II. Some cases of PIVKA-II- and AFP-producing advanced gastric cancer with liver metastasis have been reported, but this is the first report of gastric cancer without liver metastasis producing PIVKA-II alone.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15375711     DOI: 10.1007/s10147-004-0398-0

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  8 in total

Review 1.  Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma.

Authors:  Hao Xing; Cunling Yan; Liming Cheng; Nianyue Wang; Shuyang Dai; Jianyong Yuan; Wenfeng Lu; Zhouchong Wang; Jun Han; Yijie Zheng; Tian Yang
Journal:  Tumour Biol       Date:  2016-10-13

2.  Protein induced by vitamin K absence or antagonist II-producing gastric cancer.

Authors:  Yoshihisa Takahashi; Tohru Inoue; Toshio Fukusato
Journal:  World J Gastrointest Pathophysiol       Date:  2010-10-15

3.  Clinical utility of protein induced by vitamin K absence in patients with chronic hepatitis B virus infection.

Authors:  Bui Xuan Truong; Yoshihiko Yano; Vu Tuong VAN; Yasushi Seo; Nguyen Hoai Nam; Nguyen Khanh Trach; Takako Utsumi; Takeshi Azuma; Yoshitake Hayashi
Journal:  Biomed Rep       Date:  2012-08-24

4.  Hepatoid carcinoma of the pancreas producing protein induced by vitamin K absence or antagonist II (PIVKA-II) and alpha-fetoprotein (AFP).

Authors:  Kazuhiro Matsueda; Hiroshi Yamamoto; Yasuo Yoshida; Kenji Notohara
Journal:  J Gastroenterol       Date:  2006-11-09       Impact factor: 6.772

5.  Primary colon cancer with a high serum PIVKA-II level.

Authors:  Kazuya Kato; Yoshiaki Iwasaki; Masahiko Taniguchi; Kazuhiko Onodera; Minoru Matsuda; Takako Kawakami; Mineko Higuchi; Kimitaka Kato; Yurina Kato; Hiroyuki Furukawa
Journal:  Int J Surg Case Rep       Date:  2014-12-04

6.  Prolonged Survival in a Case of Chemotherapy-Sensitive Gastric Cancer That Produced Alpha-Fetoprotein and Protein Induced by Vitamin K Antagonist-II.

Authors:  Naotaka Ogasawara; Emiko Takahashi; Tomoko Matsumoto; Manami Amaike; Mako Nohara; Kazuhiro Nagao; Masahide Ebi; Yasushi Funaki; Makoto Sasaki; Kunio Kasugai
Journal:  Case Rep Gastroenterol       Date:  2015-04-24

7.  The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinoma.

Authors:  Keun Hee Kang; Ji Hoon Kim; Seong Hee Kang; Beom Jae Lee; Yeon Seok Seo; Hyung Joon Yim; Jong Eun Yeon; Jong Jae Park; Jae Seon Kim; Young Tae Bak; Kwan Soo Byun
Journal:  Gut Liver       Date:  2015-03       Impact factor: 4.519

8.  Protein Induced by Vitamin K Absence II (PIVKA-II) as a potential serological biomarker in pancreatic cancer: a pilot study.

Authors:  Sara Tartaglione; Irene Pecorella; Serena Rita Zarrillo; Teresa Granato; Valentina Viggiani; Lucia Manganaro; Cinzia Marchese; Antonio Angeloni; Emanuela Anastasi
Journal:  Biochem Med (Zagreb)       Date:  2019-06-15       Impact factor: 2.313

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.